Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HB1801 versus Taxotere in advanced breast cancer
CTR20252693Phase 2Active
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Aug 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of albumin-bound docetaxel, docetaxel in breast cancer, sponsored by CSPC ZhongQi Pharmaceutical Technology. Started Aug 2025; status: active.
02
Drugs
albumin-bound docetaxeldocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20252693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252693.